Reporting of the balance/trade-off between benefits and harms/side effects/risks Recommendations reflect considerations of both benefits and harms/side effects/risks 12. LINK BETWEEN How the guideline development group linked and RECOMMENDATIONS AND EVIDENCE used the evidence to inform recommendations Describe the explicit link between the Link between each recommendation and key recommendations and the evidence on evidence (text description and/or reference list) which they are based. Link between recommendations and evidence summaries and/or evidence tables in the results section of the guideline 13. EXTERNAL REVIEW Purpose and intent of the external review (e.g., to Report the methodology used to conduct improve quality, gather feedback on draft the external review. recommendations, assess applicability and feasibility, disseminate evidence) Methods taken to undertake the external review (e.g., rating scale, open-ended questions) Description of the external reviewers (e.g., number, type of reviewers, affiliations) Outcomes/information gathered from the external review (e.g., summary of key findings) How the information gathered was used to inform the guideline development process and/or formation of the recommendations (e.g., guideline panel considered results of review in forming final recommendations) 14. UPDATING PROCEDURE A statement that the guideline will be updated Describe the procedure for updating the Explicit time interval or explicit criteria to guide guideline. decisions about when an update will occur Methodology for the updating procedure DOMAIN 4: CLARITY OF PRESENTATION 15. SPECIFIC AND UNAMBIGUOUS A statement of the recommended action RECOMMENDATIONS Intent or purpose of the recommended action (e.g., Describe which options are appropriate in to improve quality of life, to decrease side which situations and in which population effects) groups, as informed by the body of Relevant population (e.g., patients, public) evidence. Caveats or qualifying statements, if relevant (e.g., patients or conditions for whom the recommendations would not apply) If is uncertainty about the best care option(s), the uncertainty should be stated in the guideline 16. MANAGEMENT OPTIONS Description of management options Describe the different options for Population or clinical situation most appropriate managing the condition or health issue. to each option
Reporting of the balance/trade-off between benefits and harms/side effects/risks Recommendations reflect considerations of both benefits and harms/side effects/risks 12. LINK BETWEEN RECOMMENDATIONS AND EVIDENCE Describe the explicit link between the recommendations and the evidence on which they are based. How the guideline development group linked and used the evidence to inform recommendations Link between each recommendation and key evidence (text description and/or reference list) Link between recommendations and evidence summaries and/or evidence tables in the results section of the guideline 13. EXTERNAL REVIEW Report the methodology used to conduct the external review. Purpose and intent of the external review (e.g., to improve quality, gather feedback on draft recommendations, assess applicability and feasibility, disseminate evidence) Methods taken to undertake the external review (e.g., rating scale, open-ended questions) Description of the external reviewers (e.g., number, type of reviewers, affiliations) Outcomes/information gathered from the external review (e.g., summary of key findings) How the information gathered was used to inform the guideline development process and/or formation of the recommendations (e.g., guideline panel considered results of review in forming final recommendations) 14. UPDATING PROCEDURE Describe the procedure for updating the guideline. A statement that the guideline will be updated Explicit time interval or explicit criteria to guide decisions about when an update will occur Methodology for the updating procedure DOMAIN 4: CLARITY OF PRESENTATION 15. SPECIFIC AND UNAMBIGUOUS RECOMMENDATIONS Describe which options are appropriate in which situations and in which population groups, as informed by the body of evidence. A statement of the recommended action Intent or purpose of the recommended action (e.g., to improve quality of life, to decrease side effects) Relevant population (e.g., patients, public) Caveats or qualifying statements, if relevant (e.g., patients or conditions for whom the recommendations would not apply) If is uncertainty about the best care option(s), the uncertainty should be stated in the guideline 16. MANAGEMENT OPTIONS Describe the different options for managing the condition or health issue. Description of management options Population or clinical situation most appropriate to each option
AGREE-Reporting-Guideline-Checklist.docx